Semin Neurol 2017; 37(04): 395-406
DOI: 10.1055/s-0037-1604351
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Sleep Disturbance, Cognitive Decline, and Dementia: A Review

Alexandra M.V. Wennberg
1   Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
,
Mark N. Wu
2   Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland
3   Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, Maryland
,
Paul B. Rosenberg
4   Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland
,
Adam P. Spira
4   Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland
5   Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
6   Johns Hopkins Center on Aging and Health, Baltimore, Maryland
› Author Affiliations
Further Information

Publication History

Publication Date:
24 August 2017 (online)

Abstract

Approximately half of older people report sleep disturbances, which are associated with various health conditions, including neurodegenerative disease and dementia. Indeed, 60 to 70% of people with cognitive impairment or dementia have sleep disturbances, which are linked to poorer disease prognosis. Sleep disturbances in people with dementia have long been recognized and studied; however, in the past 10 years, researchers have begun to study disturbed sleep, including sleep fragmentation, abnormal sleep duration, and sleep disorders, as risk factors for dementia. In this review the authors summarize evidence linking sleep disturbance and dementia. They describe how specific aspects of sleep (e.g., quality, duration) and the prevalence of clinical sleep disorders (e.g., sleep-disordered breathing, rapid eye movement sleep behavior disorder) change with age; how sleep parameters and sleep disorders are associated with the risk of dementia; how sleep can be disturbed in dementia; and how disturbed sleep affects dementia prognosis. These findings highlight the potential importance of identifying and treating sleep problems and disorders in middle-aged and older adults as a strategy to prevent cognitive decline and dementia. The authors also review recent evidence linking sleep disturbances to the pathophysiology underlying dementing conditions, and briefly summarize available treatments for sleep disorders in people with dementia.

 
  • References

  • 1 Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004; 27 (07) 1255-1273
  • 2 Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004; 56 (05) 497-502
  • 3 Berry RB, Brooks R, Gamaldo CE. , et al. The AASM Manual for the Scoring of Sleep and Associated Events. Vol 2.2. Darien, IL: American Academy of Sleep Medicine; 2015
  • 4 Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic neurons during sleep. Science 1996; 271 (5246): 216-219
  • 5 Lu J, Greco MA, Shiromani P, Saper CB. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 2000; 20 (10) 3830-3842
  • 6 Buijs RM, Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci 2001; 2 (07) 521-526
  • 7 Hofman MA, Swaab DF. Living by the clock: the circadian pacemaker in older people. Ageing Res Rev 2006; 5 (01) 33-51
  • 8 Yoon IY, Kripke DF, Elliott JA, Youngstedt SD, Rex KM, Hauger RL. Age-related changes of circadian rhythms and sleep-wake cycles. J Am Geriatr Soc 2003; 51 (08) 1085-1091
  • 9 Wang JL, Lim AS, Chiang WY. , et al. Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Ann Neurol 2015; 78 (02) 317-322
  • 10 Kondratova AA, Kondratov RV. The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 2012; 13 (05) 325-335
  • 11 Rongve A, Boeve BF, Aarsland D. Frequency and correlates of caregiver-reported sleep disturbances in a sample of persons with early dementia. J Am Geriatr Soc 2010; 58 (03) 480-486
  • 12 Gagnon JF, Petit D, Latreille V, Montplaisir J. Neurobiology of sleep disturbances in neurodegenerative disorders. Curr Pharm Des 2008; 14 (32) 3430-3445
  • 13 Marion MH, Qurashi M, Marshall G, Foster O. Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?. J Neurol 2008; 255 (02) 192-196
  • 14 Naismith SL, Glozier N, Burke D, Carter PE, Scott E, Hickie IB. Early intervention for cognitive decline: is there a role for multiple medical or behavioural interventions?. Early Interv Psychiatry 2009; 3 (01) 19-27
  • 15 Naismith SL, Norrie L, Lewis SJ, Rogers NL, Scott EM, Hickie IB. Does sleep disturbance mediate neuropsychological functioning in older people with depression?. J Affect Disord 2009; 116 (1-2): 139-143
  • 16 Vendette M, Gagnon JF, Décary A. , et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 2007; 69 (19) 1843-1849
  • 17 Naismith SL, Hickie IB, Lewis SJ. The role of mild depression in sleep disturbance and quality of life in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2010; 22 (04) 384-389
  • 18 Naismith SL, Rogers NL, Lewis SJ. , et al. Sleep disturbance relates to neuropsychological functioning in late-life depression. J Affect Disord 2011; 132 (1-2): 139-145
  • 19 Pat-Horenczyk R, Klauber MR, Shochat T, Ancoli-Israel S. Hourly profiles of sleep and wakefulness in severely versus mild-moderately demented nursing home patients. Aging (Milano) 1998; 10 (04) 308-315
  • 20 Yaffe K, Blackwell T, Barnes DE, Ancoli-Israel S, Stone KL. ; Study of Osteoporotic Fractures Group. Preclinical cognitive decline and subsequent sleep disturbance in older women. Neurology 2007; 69 (03) 237-242
  • 21 Kronholm E, Sallinen M, Suutama T, Sulkava R, Era P, Partonen T. Self-reported sleep duration and cognitive functioning in the general population. J Sleep Res 2009; 18 (04) 436-446
  • 22 Ohayon MM, Vecchierini MF. Daytime sleepiness and cognitive impairment in the elderly population. Arch Intern Med 2002; 162 (02) 201-208
  • 23 Schmutte T, Harris S, Levin R, Zweig R, Katz M, Lipton R. The relation between cognitive functioning and self-reported sleep complaints in nondemented older adults: results from the Bronx aging study. Behav Sleep Med 2007; 5 (01) 39-56
  • 24 Sternberg DA, Ballard K, Hardy JL, Katz B, Doraiswamy PM, Scanlon M. The largest human cognitive performance dataset reveals insights into the effects of lifestyle factors and aging. Front Hum Neurosci 2013; 7: 292
  • 25 Tworoger SS, Lee S, Schernhammer ES, Grodstein F. The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Dis Assoc Disord 2006; 20 (01) 41-48
  • 26 Xu L, Jiang CQ, Lam TH. , et al. Short or long sleep duration is associated with memory impairment in older Chinese: the Guangzhou Biobank Cohort Study. Sleep 2011; 34 (05) 575-580
  • 27 Ohayon MM, Vecchierini MF. Normative sleep data, cognitive function and daily living activities in older adults in the community. Sleep 2005; 28 (08) 981-989
  • 28 Faubel R, López-García E, Guallar-Castillón P, Graciani A, Banegas JR, Rodríguez-Artalejo F. Usual sleep duration and cognitive function in older adults in Spain. J Sleep Res 2009; 18 (04) 427-435
  • 29 Ramos AR, Dong C, Elkind MS. , et al. Association between sleep duration and the mini-mental score: the Northern Manhattan study. J Clin Sleep Med 2013; 9 (07) 669-673
  • 30 Ferrie JE, Shipley MJ, Akbaraly TN, Marmot MG, Kivimäki M, Singh-Manoux A. Change in sleep duration and cognitive function: findings from the Whitehall II Study. Sleep 2011; 34 (05) 565-573
  • 31 Loerbroks A, Debling D, Amelang M, Stürmer T. Nocturnal sleep duration and cognitive impairment in a population-based study of older adults. Int J Geriatr Psychiatry 2010; 25 (01) 100-109
  • 32 Lo JC, Groeger JA, Cheng GH, Dijk DJ, Chee MW. Self-reported sleep duration and cognitive performance in older adults: a systematic review and meta-analysis. Sleep Med 2016; 17: 87-98
  • 33 Benito-León J, Louis ED, Bermejo-Pareja F. Cognitive decline in short and long sleepers: a prospective population-based study (NEDICES). J Psychiatr Res 2013; 47 (12) 1998-2003
  • 34 Virta JJ, Heikkilä K, Perola M. , et al. Midlife sleep characteristics associated with late life cognitive function. Sleep 2013; 36 (10) 1533-1541 , 1541A
  • 35 Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991; 14 (06) 486-495
  • 36 Ancoli-Israel S, Palmer BW, Cooke JR. , et al. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J Am Geriatr Soc 2008; 56 (11) 2076-2081
  • 37 Bixler EO, Vgontzas AN, Lin HM. , et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163 (3 Pt 1): 608-613
  • 38 Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157 (01) 144-148
  • 39 Young T, Shahar E, Nieto FJ. , et al; Sleep Heart Health Study Research Group. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162 (08) 893-900
  • 40 Ancoli-Israel S, Klauber MR, Butters N, Parker L, Kripke DF. Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc 1991; 39 (03) 258-263
  • 41 Bucks RS, Olaithe M, Eastwood P. Neurocognitive function in obstructive sleep apnoea: a meta-review. Respirology 2013; 18 (01) 61-70
  • 42 Wallace A, Bucks RS. Memory and obstructive sleep apnea: a meta-analysis. Sleep 2013; 36 (02) 203-220
  • 43 Aloia MS, Arnedt JT, Davis JD, Riggs RL, Byrd D. Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review. J Int Neuropsychol Soc 2004; 10 (05) 772-785
  • 44 Yaffe K, Laffan AM, Harrison SL. , et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011; 306 (06) 613-619
  • 45 Chang WP, Liu ME, Chang WC. , et al. Sleep apnea and the risk of dementia: a population-based 5-year follow-up study in Taiwan. PLoS One 2013; 8 (10) e78655
  • 46 Osorio RS, Gumb T, Pirraglia E. , et al; Alzheimer's Disease Neuroimaging Initiative. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 2015; 84 (19) 1964-1971
  • 47 Jaussent I, Bouyer J, Ancelin ML. , et al. Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep 2012; 35 (09) 1201-1207
  • 48 Möller C, Hafkemeijer A, Pijnenburg YAL. , et al. Different patterns of cortical gray matter loss over time in behavioral variant frontotemporal dementia and Alzheimer's disease. Neurobiol Aging 2016; 38: 21-31
  • 49 Zarei M, Ibarretxe-Bilbao N, Compta Y. , et al. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2013; 84 (08) 875-881
  • 50 Lim AS, Fleischman DA, Dawe RJ. , et al. Regional neocortical gray matter structure and sleep fragmentation in older adults. Sleep 2016; 39 (01) 227-235
  • 51 Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003; 26 (03) 342-392
  • 52 Spira AP, Gonzalez CE, Venkatraman VK. , et al. Sleep duration and subsequent cortical thinning in cognitively normal older adults. Sleep 2016; 39 (05) 1121-1128
  • 53 Lo JC, Loh KK, Zheng H, Sim SK, Chee MW. Sleep duration and age-related changes in brain structure and cognitive performance. Sleep 2014; 37 (07) 1171-1178
  • 54 Tononi G, Cirelli C. Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration. Neuron 2014; 81 (01) 12-34
  • 55 Kreutzmann JC, Havekes R, Abel T, Meerlo P. Sleep deprivation and hippocampal vulnerability: changes in neuronal plasticity, neurogenesis and cognitive function. Neuroscience 2015; 309: 173-190
  • 56 Joo EY, Jeon S, Kim ST, Lee JM, Hong SB. Localized cortical thinning in patients with obstructive sleep apnea syndrome. Sleep 2013; 36 (08) 1153-1162
  • 57 Kumar R, Birrer BV, Macey PM. , et al. Reduced mammillary body volume in patients with obstructive sleep apnea. Neurosci Lett 2008; 438 (03) 330-334
  • 58 Macey PM, Kumar R, Woo MA, Valladares EM, Yan-Go FL, Harper RM. Brain structural changes in obstructive sleep apnea. Sleep 2008; 31 (07) 967-977
  • 59 Zimmerman ME, Aloia MS. A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med 2006; 2 (04) 461-471
  • 60 Kim H, Yun CH, Thomas RJ. , et al. Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population. Sleep 2013; 36 (05) 709-715B
  • 61 Cho ER, Kim H, Seo HS, Suh S, Lee SK, Shin C. Obstructive sleep apnea as a risk factor for silent cerebral infarction. J Sleep Res 2013; 22 (04) 452-458
  • 62 Castronovo V, Scifo P, Castellano A. , et al. White matter integrity in obstructive sleep apnea before and after treatment. Sleep 2014; 37 (09) 1465-1475
  • 63 Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172 (11) 1447-1451
  • 64 Hermann DM, Bassetti CL. Sleep-related breathing and sleep-wake disturbances in ischemic stroke. Neurology 2009; 73 (16) 1313-1322
  • 65 Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464): 1046-1053
  • 66 Redline S, Yenokyan G, Gottlieb DJ. , et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010; 182 (02) 269-277
  • 67 Cermakova P, Eriksdotter M, Lund LH, Winblad B, Religa P, Religa D. Heart failure and Alzheimer's disease. J Intern Med 2015; 277 (04) 406-425
  • 68 Ju YE, McLeland JS, Toedebusch CD. , et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol 2013; 70 (05) 587-593
  • 69 Alzheimer's Association. 2016 Alzheimer's disease facts and figures. Alzheimers Dement 2016; 12 (04) 459-509
  • 70 Jack CR, Knopman DS, Jagust WJ. , et al. Update on hypothetical model of Alzheimer's disease biomarkers. Lancet Neurol 2013; 12 (02) 207-216
  • 71 Guarnieri B, Adorni F, Musicco M. , et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord 2012; 33 (01) 50-58
  • 72 Bliwise DL, Watts RL, Watts N, Rye DB, Irbe D, Hughes M. Disruptive nocturnal behavior in Parkinson's disease and Alzheimer's disease. J Geriatr Psychiatry Neurol 1995; 8 (02) 107-110
  • 73 Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med 2005; 6 (04) 347-352
  • 74 Hatfield CF, Herbert J, van Someren EJ, Hodges JR, Hastings MH. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 2004; 127 (Pt 5): 1061-1074
  • 75 Benito-León J, Bermejo-Pareja F, Vega S, Louis ED. Total daily sleep duration and the risk of dementia: a prospective population-based study. Eur J Neurol 2009; 16 (09) 990-997
  • 76 Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep 2013; 36 (07) 1027-1032
  • 77 Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 2013; 70 (12) 1544-1551
  • 78 Osorio RS, Pirraglia E, Agüera-Ortiz LF. , et al. Greater risk of Alzheimer's disease in older adults with insomnia. J Am Geriatr Soc 2011; 59 (03) 559-562
  • 79 Lobo A, López-Antón R, de-la-Cámara C, Quintanilla MA, Campayo A, Saz P. ; ZARADEMP Workgroup. Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia, Alzheimer's type. Neurotox Res 2008; 14 (2-3): 263-272
  • 80 Kang JE, Lim MM, Bateman RJ. , et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009; 326 (5955): 1005-1007
  • 81 Roh JH, Huang Y, Bero AW. , et al. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 2012; 4 (150) 150ra122
  • 82 Spira AP, An Y, Resnick SM. Self-reported sleep and β-amyloid deposition in older adults-reply. JAMA Neurol 2014; 71 (05) 651-652
  • 83 Fagan AM, Mintun MA, Mach RH. , et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 2006; 59 (03) 512-519
  • 84 Tabuchi M, Lone SR, Liu S. , et al. Sleep interacts with aβ to modulate intrinsic neuronal excitability. Curr Biol 2015; 25 (06) 702-712
  • 85 Palop JJ, Mucke L, Roberson ED. Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling. Methods Mol Biol 2011; 670: 245-262
  • 86 Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: a beginner's guide. Neurochem Res 2015; 40 (12) 2583-2599
  • 87 Mendelsohn AR, Larrick JW. Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases. Rejuvenation Res 2013; 16 (06) 518-523
  • 88 Iliff JJ, Wang M, Liao Y. , et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 2012; 4 (147) 147ra111
  • 89 Kress BT, Iliff JJ, Xia M. , et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 2014; 76 (06) 845-861
  • 90 Xie L, Kang H, Xu Q. , et al. Sleep drives metabolite clearance from the adult brain. Science 2013; 342 (6156): 373-377
  • 91 Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer's disease?. Trends Neurosci 2016; 39 (08) 552-566
  • 92 Mishima K, Okawa M, Satoh K, Shimizu T, Hozumi S, Hishikawa Y. Different manifestations of circadian rhythms in senile dementia of Alzheimer's type and multi-infarct dementia. Neurobiol Aging 1997; 18 (01) 105-109
  • 93 Satlin A, Volicer L, Stopa EG, Harper D. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol Aging 1995; 16 (05) 765-771
  • 94 Ancoli-Israel S, Klauber MR, Jones DW. , et al. Variations in circadian rhythms of activity, sleep, and light exposure related to dementia in nursing-home patients. Sleep 1997; 20 (01) 18-23
  • 95 Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry 2005; 13 (05) 359-368
  • 96 Harper DG, Stopa EG, Kuo-Leblanc V. , et al. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain 2008; 131 (Pt 6): 1609-1617
  • 97 Lim AS, Ellison BA, Wang JL. , et al. Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease. Brain 2014; 137 (Pt 10): 2847-2861
  • 98 Tranah GJ, Blackwell T, Stone KL. , et al; SOF Research Group. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol 2011; 70 (05) 722-732
  • 99 Emamian F, Khazaie H, Tahmasian M. , et al. The association between obstructive sleep apnea and Alzheimer's disease: a meta-analysis perspective. Front Aging Neurosci 2016; 8: 78
  • 100 Daulatzai MA. Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome. Neurotox Res 2013; 24 (02) 216-243
  • 101 Li L, Zhang X, Yang D, Luo G, Chen S, Le W. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Neurobiol Aging 2009; 30 (07) 1091-1098
  • 102 Fang H, Zhang LF, Meng FT, Du X, Zhou JN. Acute hypoxia promote the phosphorylation of tau via ERK pathway. Neurosci Lett 2010; 474 (03) 173-177
  • 103 Ju YE, Finn MB, Sutphen CL. , et al. Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid. Ann Neurol 2016; 80 (01) 154-159
  • 104 Osorio RS, Ayappa I, Mantua J. , et al. Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiol Aging 2014; 35 (06) 1318-1324
  • 105 Spira AP, Yager C, Brandt J. , et al. Objectively measured sleep and β-amyloid burden in older adults: a pilot study. SAGE Open Med 2014; 2: 2
  • 106 Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med 2003; 348 (14) 1356-1364
  • 107 Bassetti CL. Nonmotor disturbances in Parkinson's disease. Neurodegener Dis 2011; 8 (03) 95-108
  • 108 Simuni T, Sethi K. Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008; 64 (Suppl. 02) S65-S80
  • 109 Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990; 5 (04) 280-285
  • 110 Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988; 11 (06) 512-519
  • 111 Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998; 13 (06) 895-899
  • 112 Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?. Neurology 2006; 67 (05) 853-858
  • 113 Svensson E, Beiske AG, Loge JH, Beiske KK, Sivertsen B. Sleep problems in Parkinson's disease: a community-based study in Norway. BMC Neurol 2012; 12: 71
  • 114 Zoccolella S, Savarese M, Lamberti P, Manni R, Pacchetti C, Logroscino G. Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies. Sleep Med Rev 2011; 15 (01) 41-50
  • 115 Barone P, Antonini A, Colosimo C. , et al; PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24 (11) 1641-1649
  • 116 Bjørnarå KA, Dietrichs E, Toft M. Clinical features associated with sleep disturbances in Parkinson's disease. Clin Neurol Neurosurg 2014; 124: 37-43
  • 117 Kurtis MM, Rodriguez-Blazquez C, Martinez-Martin P. ; ELEP Group. Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2013; 19 (12) 1152-1155
  • 118 Borek LL, Kohn R, Friedman JH. Mood and sleep in Parkinson's disease. J Clin Psychiatry 2006; 67 (06) 958-963
  • 119 Chahine LM, Daley J, Horn S. , et al. Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease. Parkinsonism Relat Disord 2013; 19 (10) 859-863
  • 120 Happe S, Lüdemann P, Berger K. ; FAQT study investigators. The association between disease severity and sleep-related problems in patients with Parkinson's disease. Neuropsychobiology 2002; 46 (02) 90-96
  • 121 Scullin MK, Sollinger AB, Land J. , et al. Sleep and impulsivity in Parkinson's disease. Parkinsonism Relat Disord 2013; 19 (11) 991-994
  • 122 Verbaan D, van Rooden SM, Visser M, Marinus J, van Hilten JJ. Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov Disord 2008; 23 (01) 35-41
  • 123 Zhu K, van Hilten JJ, Marinus J. The course of insomnia in Parkinson's disease. Parkinsonism Relat Disord 2016; 33: 51-57
  • 124 Trenkwalder C, Allen R, Högl B, Paulus W, Winkelmann J. Restless legs syndrome associated with major diseases: a systematic review and new concept. Neurology 2016; 86 (14) 1336-1343
  • 125 Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M. Restless legs syndrome in Parkinson's disease. Parkinsonism Relat Disord 2014; 20 (Suppl. 01) S5-S9
  • 126 da Silva-Júnior Jr FP, do Prado GF, Barbosa ER, Tufik S, Togeiro SM. Sleep disordered breathing in Parkinson's disease: a critical appraisal. Sleep Med Rev 2014; 18 (02) 173-178
  • 127 Harmell AL, Neikrug AB, Palmer BW. , et al. Obstructive sleep apnea and cognition in Parkinson's disease. Sleep Med 2016; 21: 28-34
  • 128 Herer B, Arnulf I, Housset B. Effects of levodopa on pulmonary function in Parkinson's disease. Chest 2001; 119 (02) 387-393
  • 129 Hovestadt A, Bogaard JM, Meerwaldt JD, van der Meché FG, Stigt J. Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989; 52 (03) 329-333
  • 130 Boeve BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 2010; 1184: 15-54
  • 131 Schenck CH, Mahowald MW. Rapid eye movement sleep parasomnias. Neurol Clin 2005; 23 (04) 1107-1126
  • 132 Ohayon MM, Caulet M, Priest RG. Violent behavior during sleep. J Clin Psychiatry 1997; 58 (08) 369-376 , quiz 377
  • 133 Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010; 75 (06) 494-499
  • 134 Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996; 46 (02) 388-393
  • 135 Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004; 17 (03) 146-157
  • 136 Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998; 51 (02) 526-529
  • 137 Gagnon JF, Bédard MA, Fantini ML. , et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002; 59 (04) 585-589
  • 138 Plazzi G, Corsini R, Provini F. , et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997; 48 (04) 1094-1097
  • 139 Tachibana N, Oka Y. Longitudinal change in REM sleep components in a patient with multiple system atrophy associated with REM sleep behavior disorder: paradoxical improvement of nocturnal behaviors in a progressive neurodegenerative disease. Sleep Med 2004; 5 (02) 155-158
  • 140 Silber MH, Ahlskog JE. REM sleep behavior disorder in Parkinsonian syndromes. Sleep Res 1992; 21: 313
  • 141 Silber MH, Dexter DD, Ahlskog JE, Hauri PJ, Shepard JW. Abnormal REM sleep motor activity in untreated Parkinson's disease. Sleep Res 1993; 22: 274
  • 142 Jennum P, Christensen JA, Zoetmulder M. Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development. Nat Sci Sleep 2016; 8: 107-120
  • 143 Kudo T, Loh DH, Truong D, Wu Y, Colwell CS. Circadian dysfunction in a mouse model of Parkinson's disease. Exp Neurol 2011; 232 (01) 66-75
  • 144 Politis M, Piccini P, Pavese N, Koh SB, Brooks DJ. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study. Exp Neurol 2008; 214 (01) 112-116
  • 145 Nakamura TJ, Nakamura W, Yamazaki S. , et al. Age-related decline in circadian output. J Neurosci 2011; 31 (28) 10201-10205
  • 146 Wu YH, Swaab DF. The human pineal gland and melatonin in aging and Alzheimer's disease. J Pineal Res 2005; 38 (03) 145-152
  • 147 Videnovic A, Noble C, Reid KJ. , et al. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 2014; 71 (04) 463-469
  • 148 Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24 (02) 197-211
  • 149 Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001; 24 (12) 726-731
  • 150 Trotti LM, Rye DB. Neurobiology of sleep: the role of dopamine in Parkinson's disease. In: Chaudruri KR, Tolosa E, Scapira A, Poewe W. , eds. Nonmotor symptoms in Parkinson's disease. New York, NY: Oxford University Press; 2009: 165-176
  • 151 Jackson CR, Chaurasia SS, Hwang CK, Iuvone PM. Dopamine D4 receptor activation controls circadian timing of the adenylyl cyclase 1/cyclic AMP signaling system in mouse retina. Eur J Neurosci 2011; 34 (01) 57-64
  • 152 Witkovsky P. Dopamine and retinal function. Doc Ophthalmol 2004; 108 (01) 17-40
  • 153 Roth HL. Dementia and sleep. Neurol Clin 2012; 30 (04) 1213-1248
  • 154 Urrestarazu E, Iriarte J. Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies. Nat Sci Sleep 2016; 8: 21-33
  • 155 Etters L, Goodall D, Harrison BE. Caregiver burden among dementia patient caregivers: a review of the literature. J Am Acad Nurse Pract 2008; 20 (08) 423-428
  • 156 Pollak CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 1991; 4 (04) 204-210
  • 157 Ooms S, Ju YE. Treatment of sleep disorders in dementia. Curr Treat Options Neurol 2016; 18 (09) 40
  • 158 Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, Nóbrega OT. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Am J Geriatr Psychiatry 2014; 22 (12) 1565-1574
  • 159 Grippe TC, Gonçalves BS, Louzada LL. , et al. Circadian rhythm in Alzheimer disease after trazodone use. Chronobiol Int 2015; 32 (09) 1311-1314
  • 160 Meguro K, Meguro M, Tanaka Y, Akanuma K, Yamaguchi K, Itoh M. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease. J Geriatr Psychiatry Neurol 2004; 17 (02) 61-67
  • 161 Ruths S, Straand J, Nygaard HA, Bjorvatn B, Pallesen S. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. J Am Geriatr Soc 2004; 52 (10) 1737-1743
  • 162 Yin Y, Liu Y, Zhuang J. , et al. Low-dose atypical antipsychotic risperidone improves the 5-year outcome in Alzheimer's disease patients with sleep disturbances. Pharmacology 2015; 96 (3-4): 155-162
  • 163 Maust DT, Kim HM, Seyfried LS. , et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry 2015; 72 (05) 438-445
  • 164 Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294 (15) 1934-1943
  • 165 Romeo R, Knapp M, Hellier J. , et al. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. Br J Psychiatry 2013; 202: 121-128
  • 166 Xu J, Wang LL, Dammer EB. , et al. Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials. Am J Alzheimers Dis Other Demen 2015; 30 (05) 439-447
  • 167 Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry 2009; 17 (02) 166-169
  • 168 Trotti LM, Karroum EG. Melatonin for sleep disorders in patients with neurodegenerative diseases. Curr Neurol Neurosci Rep 2016; 16 (07) 63
  • 169 Wu YH, Zhou JN, Van Heerikhuize J, Jockers R, Swaab DF. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Neurobiol Aging 2007; 28 (08) 1239-1247
  • 170 Golombek DA, Pandi-Perumal SR, Brown GM, Cardinali DP. Some implications of melatonin use in chronopharmacology of insomnia. Eur J Pharmacol 2015; 762: 42-48
  • 171 Shochat T, Martin J, Marler M, Ancoli-Israel S. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res 2000; 9 (04) 373-379
  • 172 Forbes D, Blake CM, Thiessen EJ, Peacock S, Hawranik P. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev 2014; (02) CD003946
  • 173 Naismith SL, Lewis SJ, Rogers NL. Sleep-wake changes and cognition in neurodegenerative disease. Prog Brain Res 2011; 190: 21-52
  • 174 Cusso ME, Donald KJ, Khoo TK. The impact of physical activity on non-motor symptoms in Parkinson's disease: a systematic review. Front Med (Lausanne) 2016; 3: 35
  • 175 McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial. J Am Geriatr Soc 2011; 59 (08) 1393-1402
  • 176 Eugster L, Bargiotas P, Bassetti CL, Michael Schuepbach WM. Deep brain stimulation and sleep-wake functions in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2016; 32: 12-19
  • 177 Cohen-Mansfield J, Garfinkel D, Lipson S. Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study. Arch Gerontol Geriatr 2000; 31 (01) 65-76
  • 178 Mishima K, Okawa M, Hozumi S, Hishikawa Y. Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons. Chronobiol Int 2000; 17 (03) 419-432
  • 179 Brusco LI, Márquez M, Cardinali DP. Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease. Neuroendocrinol Lett 2000; 21 (01) 39-42
  • 180 Dowling GA, Burr RL, Van Someren EJ. , et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 2008; 56 (02) 239-246
  • 181 Rodrigues TM, Castro Caldas A, Ferreira JJ. Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: systematic review and meta-analysis. Parkinsonism Relat Disord 2016; 27: 25-34
  • 182 Ayalon L, Ancoli-Israel S, Stepnowsky C. , et al. Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. Am J Geriatr Psychiatry 2006; 14 (02) 176-180
  • 183 Cooke JR, Ayalon L, Palmer BW. , et al. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med 2009; 5 (04) 305-309
  • 184 Archbold KH, Borghesani PR, Mahurin RK, Kapur VK, Landis CA. Neural activation patterns during working memory tasks and OSA disease severity: preliminary findings. J Clin Sleep Med 2009; 5 (01) 21-27
  • 185 Ayalon L, Ancoli-Israel S, Klemfuss Z, Shalauta MD, Drummond SP. Increased brain activation during verbal learning in obstructive sleep apnea. Neuroimage 2006; 31 (04) 1817-1825
  • 186 Thomas RJ, Rosen BR, Stern CE, Weiss JW, Kwong KK. Functional imaging of working memory in obstructive sleep-disordered breathing. J Appl Physiol (1985) 2005; 98 (06) 2226-2234
  • 187 Zhang X, Ma L, Li S, Wang Y, Wang L. A functional MRI evaluation of frontal dysfunction in patients with severe obstructive sleep apnea. Sleep Med 2011; 12 (04) 335-340
  • 188 Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003; 4 (04) 281-284
  • 189 Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999; 14 (03) 507-511
  • 190 Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123 (Pt 2): 331-339
  • 191 Schenck CH, Mahowald MW. A polysomnographic, neurologic, psychiatric and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Cleve Clin J Med 1990; 57 (supplement): 10-24
  • 192 Aurora RN, Zak RS, Maganti RK. , et al; Standards of Practice Committee; American Academy of Sleep Medicine. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 2010; 6 (01) 85-95
  • 193 Onofrj M, Luciano AL, Thomas A, Iacono D, D'Andreamatteo G. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology 2003; 60 (01) 113-115
  • 194 Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004; 27 (02) 317-321
  • 195 Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry 2013; 25 (02) 130-137
  • 196 Anderson KN, Hatfield C, Kipps C, Hastings M, Hodges JR. Disrupted sleep and circadian patterns in frontotemporal dementia. Eur J Neurol 2009; 16 (03) 317-323
  • 197 Gorelick PB, Scuteri A, Black SE. , et al; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42 (09) 2672-2713
  • 198 Kalaria RN. Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke 2012; 43 (09) 2526-2534
  • 199 Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999; 13 (Suppl. 03) S115-S123
  • 200 Oosterman J, van Harten B, Vogels R. , et al. Distortions in rest-activity rhythm in aging relate to white matter hyperintensities. Neurobiol Aging 2008; 29 (08) 1265-1271
  • 201 Foley D, Monjan A, Masaki K. , et al. Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in older Japanese-American men. J Am Geriatr Soc 2001; 49 (12) 1628-1632
  • 202 Cooke JR, Liu L, Natarajan L. , et al. The effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer's disease. Behav Sleep Med 2006; 4 (04) 219-227
  • 203 Cricco M, Simonsick EM, Foley DJ. The impact of insomnia on cognitive functioning in older adults. J Am Geriatr Soc 2001; 49 (09) 1185-1189
  • 204 Talarico G, Canevelli M, Tosto G. , et al. Restless legs syndrome in a group of patients with Alzheimer's disease. Am J Alzheimers Dis Other Demen 2013; 28 (02) 165-170